project id: TCGA-UCEC; case submitter id: TCGA-FI-A2D2; source center: 23; state: released; a260 a280 ratio: 1.95; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 9.0; age at index: 66; days to birth: -24260; days to death: 2352; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1942; age at diagnosis: 24260; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1215.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 975; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-FI-A2D2-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 2.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 2.0; percent tumor cells: 96.0; percent tumor nuclei: 98.0;